Savara Pharmaceuticals
SVRA
#6948
Rank
C$0.68 B
Marketcap
$4.02
Share price
0.72%
Change (1 day)
-35.37%
Change (1 year)

Earnings for Savara Pharmaceuticals (SVRA)

Earnings in 2024 (TTM): -C$0.12 Billion

According to Savara Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -C$78.73 Million a decrease over its 2022 earnings that were of -C$54.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara Pharmaceuticals from 2002 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -C$0.12 Billion42.42%
2023 -C$78.73 Million43.38%
2022 -C$54.91 Million-11.31%
2021 -C$61.91 Million-13.3%
2020 -C$71.41 Million-36.53%
2019 -C$0.12 Billion13.76%
2018 -C$98.91 Million105.54%
2017 -C$48.12 Million34.11%
2016 -C$35.88 Million-37.43%
2015 -C$57.35 Million38.81%
2014 -C$41.31 Million33.62%
2013 -C$30.92 Million38.49%
2012 -C$22.33 Million24.59%
2011 -C$17.92 Million-36.5%
2010 -C$28.22 Million-3.14%
2009 -C$29.14 Million-23.28%
2008 -C$37.98 Million8.52%
2007 -C$35 Million-34.14%
2006 -C$53.14 Million184.43%
2005 -C$18.68 Million90.75%
2004 -C$9.8 Million190.35%
2003 -C$3.38 Million11.64%
2002 -C$3.03 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-C$26.14 Million-78.11%๐Ÿ‡บ๐Ÿ‡ธ USA
-C$0.17 Billion 42.09%๐Ÿ‡บ๐Ÿ‡ธ USA